AngioDynamics, Inc. (NASDAQ:ANGO) Shares Acquired by D. E. Shaw & Co. Inc.

D. E. Shaw & Co. Inc. raised its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 13.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 247,074 shares of the medical instruments supplier's stock after acquiring an additional 28,493 shares during the period. D. E. Shaw & Co. Inc. owned approximately 0.61% of AngioDynamics worth $2,263,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. purchased a new stake in shares of AngioDynamics during the 4th quarter worth about $28,000. R Squared Ltd purchased a new position in AngioDynamics in the fourth quarter valued at approximately $49,000. US Bancorp DE lifted its position in AngioDynamics by 1,938.0% during the fourth quarter. US Bancorp DE now owns 6,705 shares of the medical instruments supplier's stock valued at $61,000 after buying an additional 6,376 shares in the last quarter. Quinn Opportunity Partners LLC purchased a new stake in AngioDynamics during the fourth quarter worth approximately $92,000. Finally, OneDigital Investment Advisors LLC increased its position in shares of AngioDynamics by 14.0% in the fourth quarter. OneDigital Investment Advisors LLC now owns 12,137 shares of the medical instruments supplier's stock worth $111,000 after acquiring an additional 1,490 shares in the last quarter. Hedge funds and other institutional investors own 89.43% of the company's stock.

AngioDynamics Trading Up 0.4%

Shares of ANGO traded up $0.04 during midday trading on Monday, reaching $9.45. 390,130 shares of the company were exchanged, compared to its average volume of 553,720. AngioDynamics, Inc. has a 1-year low of $5.47 and a 1-year high of $13.50. The company has a market cap of $383.74 million, a price-to-earnings ratio of -1.68 and a beta of 0.58. The stock has a 50-day moving average price of $9.47 and a 200-day moving average price of $9.53.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last announced its earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.16. The business had revenue of $72.00 million during the quarter, compared to the consensus estimate of $70.30 million. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. AngioDynamics's revenue for the quarter was down 4.3% compared to the same quarter last year. Equities research analysts anticipate that AngioDynamics, Inc. will post -0.37 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a "buy" rating and issued a $16.00 target price (up previously from $15.00) on shares of AngioDynamics in a research note on Monday, April 7th.

AngioDynamics Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.